AnovoRx Holdings
AnovoRx Holdings specializes in supporting rare disease drugs and launching new ones, offering integrated services including 3PL, patient services, and specialty pharmacy with a focus on personalized patient care and operational efficiency.
Services
AnovoRx Holdings provides a comprehensive range of services designed to support the pharmaceutical industry, particularly in the area of rare disease drugs. The company combines 3PL services, patient services hub, and specialty pharmacy to offer an integrated end-to-end service model. This includes benefits investigation, prior authorization support, patient case management, REMS program management, and patient adherence program administration. They also provide bridge/starter kit/PAP support, recall management, and personalized patient care. Additional services include customized patient adherence call cadence and free overnight shipping for patients.
Products
AnovoRx Holdings offers a range of rare disease medications including AGAMREE, ANASCORP, ALKINDI SPRINKLE, CARGLUMIC ACID, CYSTADANE, CYSTADROPS, DAYBUE, FINTEPLA, FIRDAPSE, ISTURISA, SIGNIFOR, SIGNIFOR LAR, TIOPRONIN DELAYED-RELEASE TABLETS, TIGLUTIK, and VIGPODER. These medications are supported by a dedicated pharmacist team ensuring product information and expertise, along with a clinical educator to support patients in meeting their treatment goals.
Quality and Compliance
AnovoRx Holdings maintains high quality and compliance standards. The company is VAWD and NCDQS accredited and complies with regulations such as 21 CFR Part 205 and DSCSA serialization. Their comprehensive quality division covers pharmacy, 3PL, HUB services, and wholesale operations. They also coordinate with reverse distributors for returns, replacements, quarantine storage, and recall management to ensure efficient operational processes and adherence to regulatory standards.
Patient Services
AnovoRx Holdings places a strong emphasis on patient services. They offer personalized patient care and support through various programs designed to aid in insurance approval and product access. This includes patient benefits, prior authorization, patient assistance, reimbursement support, clinical assessment, and management of patient compliance and adherence. The patient hub coordinates closely with the specialty pharmacy to ensure seamless service delivery and high patient satisfaction, reflected in their 99% satisfaction ratings maintained over seven years.
Locations
AnovoRx Holdings operates out of two primary locations in the United States. They have facilities in Memphis, TN, and Chandler, AZ, allowing them to effectively manage and coordinate their extensive range of services across the nation. These locations are fully licensed nationwide and DEA licensed for scheduled products, further extending their capability to serve a wider patient and client base.